Arvinas, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Arvinas, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 1.4 times its market value (net cash). Higher than 92% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 89% of Healthcare companies in United States.
- Growth Efficiency Ratio: Sales grew 100% in 3 years; of every extra $100 of sales, $154 became extra profit. Higher than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-133.5×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 85% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
$154Sales grew 100% in 3 years; of every extra $100 of sales, $154 became extra profit.
Higher than 86% of Healthcare companies in United States.
Asset Productivity Ratio
+100% / -43%In 3 years sales changed by +100% while total assets changed by -43%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-161.1×Operating cash was negative last year, while some debt falls due within a year.
Lower than 89% of Healthcare companies in United States.
Cash Cushion Ratio
1.4× cashCash, after subtracting all debt, is 1.4 times its market value (net cash).
Higher than 92% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Arvinas, Inc. owes $0.17 for every $1 it owns. Arvinas, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
29.7Investors pay $29.7 for every $1 of Arvinas, Inc.'s yearly profit, higher than 56% of Healthcare companies in United States.
P/B ratio
0.89The share price is 0.89 times Arvinas, Inc.'s book value per share, lower than 81% of Healthcare companies in United States.
Market cap
$498 MThe total market value of all of Arvinas, Inc.'s shares at today's price (share price × number of shares), larger than 55% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$562 MWhat Arvinas, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$8.71Net worth divided by the number of shares. The share price of $7.72 is 0.9 times this, which is the P/B above.
Return on equity (ROE)
1.6%Arvinas, Inc. earned 1.6% on its shareholders' money over the last year, higher than 76% of Healthcare companies in United States.
Owes vs Owns
0.17×Arvinas, Inc. owes $0.17 for every $1 it owns (low), lower than 78% of Healthcare companies in United States.
Dividend yield
NoneArvinas, Inc. does not currently pay a dividend.
Revenue growth
-0%Revenue fell 0% in the year to Dec 2025, and grew 26% a year on average over 3 years.
Profit growth
LossArvinas, Inc. made a loss in each of the last two years.
Profit margin
-30.8%Arvinas, Inc. lost $31 for every $100 of revenue.
Cash vs debt
Net cashArvinas, Inc. held $676 M more cash than debt (net cash) at Dec 2025.
Questions
What is Arvinas, Inc.'s P/E ratio?
Investors pay $29.7 for every $1 of Arvinas, Inc.'s yearly profit, higher than 56% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Arvinas, Inc.: $498 M ÷ $562 M (30 Jun 2026) = 0.9.
What is Arvinas, Inc.'s return on equity?
Arvinas, Inc. earned 1.6% on its shareholders' money over the last year, higher than 76% of Healthcare companies in United States.
How much does Arvinas, Inc. owe compared with what it owns?
Arvinas, Inc. owes $0.17 for every $1 it owns (low), lower than 78% of Healthcare companies in United States.
Does Arvinas, Inc. pay a dividend?
No. Arvinas, Inc. does not currently pay a dividend.
Is Arvinas, Inc.'s revenue growing?
Revenue fell 0% in the year to Dec 2025, and grew 26% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.